Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome

Annals of Neurology

Volumn 58, Issue 4, 2005, Pages 630-634

  Schmidauer, Christoph ^a   Sojer, Martin ^a   Seppi, Klaus ^a   Stockner, Heike ^a   Högl, Birgit ^a   Biedermann, Birgit ^a   Brandauer, Elisabeth ^a   Peralta, Cecilia M ^a   Wenning, Gregor K ^a   Poewe, Werner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; IRON; LEVODOPA;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOPPLER ECHOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; IRON DEFICIENCY; IRON TRANSPORT; KRUSKAL WALLIS TEST; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SUBSTANTIA NIGRA; TISSUE LEVEL;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 25444444501     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20572     Document Type: Article

References (15)

1. Becker G, Berg D. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord 2001;16:23-32.
2. Becker G, Seufert J, Bogdahn U, et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real time sonography. Neurology 1995;45:182-184.
3. Berg D, Siefker C, Becker G. Echogeniciry of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001;248:684-689.
4. Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999-1005.
5. Connor JR, Boyer PJ, Menzies SL, et al. Neuroparhological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-309.
6. Allen RP, Pichietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
7. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
8. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026-1031.
9. Fleiss JL, Shrout PE. The effects of measurement errors on some multivariate procedures. Am J Public Health 1997;67:1188-1191.
10. Drayer BP. Magnetic resonance imaging and extrapyramisal movement disorders. Eur Neurol 1989;29(suppl 1):9-12.
11. Alien RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-265.
12. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004;62:1563-1567.
13. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700.
14. Poewe W, Hoegl B. Akathisia, restless legs syndrome and periodic limb movements in sleep in Parkinson's disease. Neurology 2004;63:S12-S16.
15. Behnke S, Berg D, Becker G. Does ultrasound disclose a vulnerability factor for Parkinson's disease? J Neurol 2003;250(suppl 1):124-127.